Pocket Program - CROI

CROI 2013 Session 122
656 Comparison of Transient Elastography and Hepatic Gradient
Venous Pressure for Predicting Liver Complications or
Death in Patients with Hepatitis C Virus Cirrhosis
Leire Perez-Latorre* 1,2 , M Sanchez-Conde 1,2 , JM Bellon 2 , P Miralles 1,2 ,
D Rincon 1,2 , JC Lopez 1,2 , J Cosin 1,2 , R Banares 1,2,3 , and J Berenguer 1,2
1 Hosp Gregorio Maranon, Madrid, Spain;; 2 Inst de Investigacion Sanitaria
Gregorio Maranon, Madrid, Spain;; and 3 CIBEREHD, Spain
657 Worse Clinical and Immunological Outcomes Associated
with Hepatitis C Virus Infection in HIV Elite Controllers
Mohammad Sajadi*, R Redfield, and R Talwani
Inst of Human Virology, Baltimore, MD, US
658 Prognostic Utility of Transient Elastography in HIV + Patients
with Liver Cirrhosis
Maria Luisa Montes Ramirez* 1 , MA Von Wichmann 2 , J Miro 3 ,
C Quereda 4 , C Tural 5 , E Ortega 6 , J Berenguer 7 , J Sanz 8 , A Hernando 9 ,
J Arribas 1 , and GESIDA-CIRROSIS Study Group
1 Hosp Univ La Paz, IdiPaz, Madrid, Spain;; 2 Hosp de Donostia, San
Sebastian, Spain;; 3 Hosp Clin-IDIBAPS, Univ of Barcelona, Spain;; 4 Hosp
Ramon y Cajal, Madrid, Spain;; 5 Hosp Germans Trials y Pujol, Badalona,
Spain;; 6 Hosp Univ Gen de Valencia, Spain;; 7 Hosp Univ Gregorio
Maranon, Madrid, Spain;; 8 Hosp Univ Principe de Asturias, Madrid,
Spain;; and 9 Hosp 12 de Octubre, Univ Europea de Madrid, Spain
c Monday, 2:30-4 pm; Hall B2
Session 120–Poster Abstracts
Hepatitis E Virus
663 Seroepidemiology and Genotyping of Hepatitis E Virus
among MSM in the Era of cART: Taiwan
Chien-Ching Hung*, S-Y Chang, Z-Y Yang, W-C Liu, C-H Wu,
and P-J Chen
Natl Taiwan Univ Hosp and Natl Taiwan Univ Coll Med, Taipei
666
Is an Accurate Predictor of Long-term Hepatitis B Envelope
Antigen Loss in HIV/Hepatitis B Virus Co-infected Patients
Treated with Tenofovir
Anders Boyd* 1 , S Maylin 2 , C Lascoux-Combe 2 , P Miailhes 3 ,
J Gozlan 4 , C Delaugerre 2 , P-M Girard 1,4,5 , and K Lacombe 1,4,5
1 INSERM UMR-S707, France;; 2 Hosp St-Louis, AP-HP, Paris, France;;
3 Hosp Croix-Rousse, Hospices Civils de Lyon, France;; 4 Hosp St-Antoine,
AP-HP, Paris, France;; and 5 UPMC, Paris VI, France
667 History of Lamivudine Predicts Lower Likelihood of
Hepatitis B Viral Suppression on Tenofovir in HIV/Hepatitis
B Virus Co-infected Patients: The Centers for AIDS Research
Network of Integrated Clinical Systems Cohort
Nina Kim* 1 , C Rodriguez 1 , S Van Rompaey 1 , H Crane 1 , M Saag 2 ,
J Eron 3 , J Martin 4 , M Kitahata 1 , and Ctr for AIDS Res Network of Clinical
Integrated Systems
1 Univ of Washington, Seattle, US;; 2 Univ of Alabama at Birmingham, US;;
3 Univ of North Carolina at Chapel Hill, US;; and 4 Univ of California, San
Francisco, US
659 Association of HIV Mono-infection and HIV/Hepatitis C
Markers Aspartate Aminotransferase to Platelet Ratio Index
Phyllis Tien* 1,2 , R Scherzer1,2 , R Bailony1 , M Plankey3 , M Peters1 ,
G Huhn4 , and Womens Interagency HIV Study
1 2 Univ of California, San Francisco, US;; San Francisco VAMC, CA, US;;
3 4 Georgetown Univ Med Ctr, Washington, DC, US;; and Stroger Hosp and
Rush Univ, Chicago, IL, US
660
among HIV/Hepatitis C Virus Co-infected Patients
A Fernandez-Rodriguez1 , Juan Berenguer* 2 , MA Jimenez-Sousa1 ,
M Guzman-Fulgencio1 , D Micheloud2 , JC Lopez2 , E Alvarez2 , JM Bellon2 ,
P Miralles2 , and S Resino1 1 2 Natl Ctr for Microbio, Majadahonda, Madrid, Spain and Hosp Gen Univ
Gregorio Maranon, Madrid, Spain
661
Hepatitis C Virus Genotype 1 in the Setting of Low Viremic
Samples
P Braun1 , F Wiesmann1 , A Berger2 , R Kaiser3 , G Naeth1 , R Ehret4 ,
and Heribert Knechten* 1
1 2 3 PZB Aachen, Germany;; Inst of Virology, Frankfurt, Germany;; Inst of
Virology, Cologne, Germany;; and 4Med Lab Berg, Berlin, Germany
662 Sensitive Detection of Minor Variants and Viral Haplotypes
A Sethuraman1 , Y Guo1 , M Brown1 , J Toma2 , A Newton2 , W Huang2 ,
M Sugiyama3 , C Petropoulos2 , M Mizokami3 , and Ellen Paxinos* 1
1 2 Pacific Biosci, Menlo Park, CA, US;; Monogram Biosci, South San
Francisco, CA, US;; and 3 668 Intensification with Pegylated Interferon during Treatment
with Tenofovir in HIV/Hepatitis B Virus Co-infected Patients
Anders Boyd*
Res Ctr for Hepatitis and Immunology, Natl Ctr
for Global Med, Ichikawa, Japan
1 , P Miailhes2 , S Maylin3 , J Gozlan4 ,
C Lascoux-Combe3 , C Delaugerre3 , P-M Girard1,4,5 , and K Lacombe1,4,5 1 2 INSERM UMR-S707, France;; Hosp Croix-Rousse, Hospices Civils de
Lyon, France;; 3Hosp St-Louis, AP-HP, Paris, France;; 4Hosp St-Antoine,
AP-HP, Paris, France;; and 5 669
UPMC, Paris VI, France
Additional Pegylated Interferon in HBeAg + HIV Co-infected
Patients on cART Including Tenofovir: The ANRS HB01
EMVIPEG Study
Patrick Miailhes* 1 , M Maynard-Muet1 , F Carrat2 , C Lascoux-Combe3 ,
D Rey4 , P Sogni5 , S Pol5 , P Cacoub6 , F Zoulim1 , and L Piroth7 1Hospices Civils de Lyon, INSERM U1052, Croix-Rousse Hosp, Lyon,
France;; 2UMRS-707, Univ Paris 6 et INSERM, Sante Publique, APHP,
Paris, France;; 3St-Louis Hosp, APHP, Paris, France;; 4Hosp Univ, HIV
Infection Ctr, Strasbourg, France;; 5Univ Paris Descartes, INSERM
U1016, APHP, Cochin Hosp, Paris, France;; 6La Pitie-Salpetriere Hosp,
CNRS UMR 7087, Pierre et Marie Curie Univ, Paris, France;; and 7CHU Dijon and Univ of Burgundy, France
670 Brief ARV Interruptions Do Not Increase the Risk of Liver
Dual-active Treatment
Huw Price* 1 , D Dunn2 , D Pillay1 , T Zachary3 , T Vudriko4 , C Kityo3 ,
P Munderi4 , J Hakim5 , C Gilks6 , R Gilson1 , and DART Virology Group
1 2 3 Univ Coll London, UK;; MRC, London, UK;; Joint Clin Res Ctr,
Kampala, Uganda;; 4MRC/UVRI, Entebbe, Uganda;; 5Univ of Zimbabwe
Clin Res Ctr, Harare;; and 6Imperial Coll London, UK
671 Key Patterns of Mutations in Hepatitis B Virus S Open
Levels of Serum Hepatitis B Virus DNA in vivo
C Mirabelli1 , V Cento1 , C Alteri1 , R Salpini1 , M Surdo1 , M Pollicita1 ,
C Gori2 , A Bertoli1 , C-F Perno1 , and Valentina Svicher* 1
1 2 Univ of Tor Vergata Rome, Italy and Natl Inst for Infectious Diseases L
Spallanzani, Rome, Italy
Program 47
Poster Listings
672 Treatment of Hepatitis Delta with Tenofovir±Lamivudine/
Rocio Sierra-Enguita* 1 , Z Plaza 1 , V Soriano 1 , MD Gonzalez 1 , JM Benito 1 ,
A Aguilera 2 , A Mena 3 , J Pedreira 2 , L Martin-Carbonero 1 , and E Poveda 1
1 Hosp Carlos III, Madrid, Spain;; 2 Hosp Conxo-CHUS, Santiago de
Compostela, Spain;; and 3 Hosp Univ A Coruna, Spain
664 Chronic Hepatitis E Causes Rapid Progression to Liver
Karin Neukam* 1,2 , P Barreiro3 , J Echevarria4 , J Macias1 , P Labarga3 ,
A Avellon4 , M Parra-Sanchez1 , N Merchante1 , V Soriano3 , and J Pineda1 1 2 Hosp Univ de Valme, Seville, Spain;; Royal Free Hosp, London,
UK;; 3Hosp Carlos III, Madrid, Spain;; and 4 673 Seroepidemiology of Hepatitis D Virus Infection among HIV
Inst de Salud Carlos III,
Majadahonda, Spain
+
Patients with Hepatitis B Virus Co-infection: Taiwan
Sui-Yuan Chang* 1,2 , S-M Wu2 , Y-C Su2 , S-F Chang2 , W-C Liu1 ,
C-H Wu1 , and C-C Hung1,2 1 2 Natl Taiwan Univ Hosp, Taipei and Natl Taiwan Univ Coll Med, Taipei
c Tuesday, 2:30-4 pm; Hall B2
Session 122–Poster Abstracts
Hepatitis C Virus Treatment Today and Tomorrow
c Monday, 2:30-4 pm; Hall B2
Session 121–Poster Abstracts
Hepatitis B Virus
665 Virologic/Serologic Outcomes in HIV/Hepatitis B Virus
and Dual- Hepatitis B Virus Therapy: ACTG Longitudinal
Linked Randomized Trials
M Kang1 , K Hollabough1 , V Pham2 , S Koletar3 , K Wu1 , M Smurzynski1 ,
and Judith Aberg* 2
1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; New York Univ Sch of Med,
NY, US;; and 3 675
Therapy for Chronic Hepatitis C Virus Genotype 1 in Hepatitis
C Virus/HIV Co-infected Patients: Early Response and Viral
Resistance
Kenneth Sherman*
Ohio State Univ Med Ctr, Columbus, US
1 , D Bartels2 , M Bsharat2 , R Rubin2 , T Kieffer2 ,
and M Sulkowski3 1 2 Univ of Cincinnati Coll of Med, OH, US;; Vertex Pharmaceuticals Inc,
Cambridge, MA, US;; and 3Johns Hopkins Univ Sch of Med, Baltimore,
MD, US